The MEDIPSO trial, published in JAMA Dermatology in 2025, randomized patients with moderate-to-severe plaque psoriasis to a Mediterranean diet or standard dietary counseling. At 16 weeks, 47.4% of the Mediterranean group achieved PASI 75 (a 75% reduction in psoriasis severity). Zero percent of controls reached that threshold. The improvement held after adjusting for weight loss: both groups lost similar amounts. The skin cleared because of what patients ate, not because they weighed less.
That single finding elevates dietary intervention from anecdote to evidence-based treatment. PASI 75 is the same benchmark used to approve biologic drugs. When a diet achieves nearly half the response rate of adalimumab with no immunosuppression risk and no drug cost, the conversation changes.
Below, each dietary approach carries an evidence grade: A (multiple RCTs or meta-analyses), B (single RCT, strong case series, or robust mechanistic plus clinical data), or C (preliminary or mechanistic evidence only). Discuss all changes with your dermatologist before starting.
The Mediterranean Diet for Psoriasis (Grade A)
The MEDIPSO trial was not the first signal. The NutriNet-Sante cohort followed 35,735 French adults and found that higher adherence to a Mediterranean pattern (measured by the MEDI-LITE score) correlated with an odds ratio of 0.71 for severe psoriasis. Barrea et al. (2015, Journal of Translational Medicine) documented that lower Mediterranean diet adherence scores tracked directly with higher PASI scores and elevated CRP.
The diet's anti-inflammatory mechanisms are well characterized. Extra-virgin olive oil contains oleocanthal, which inhibits COX-1 and COX-2 through the same mechanism as ibuprofen. Fatty fish provides EPA and DHA, precursors to specialized pro-resolving mediators (resolvins, protectins) that actively terminate inflammatory cascades. Polyphenols from vegetables, berries, and nuts suppress NF-kB activation. Fiber from legumes and whole grains feeds butyrate-producing gut bacteria, strengthening the intestinal barrier.
What a Psoriasis Mediterranean Plate Looks Like
Fats: Extra-virgin olive oil as the primary cooking and finishing fat. Four tablespoons per day was typical in MEDIPSO. Choose dark glass bottles; refined olive oil lacks the polyphenol content that provides anti-inflammatory benefit.
Protein: Fatty fish (salmon, sardines, mackerel, anchovies) at least three times per week. Legumes (lentils, chickpeas, white beans) as the primary plant protein. Poultry in moderation. Red meat minimized to once per week or less.
Vegetables: Five or more daily servings. Emphasize leafy greens (spinach, kale, arugula), cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), and deeply colored produce (beets, berries, sweet potatoes).
Grains: Whole grains only. Oats, brown rice, quinoa, farro. No refined white flour products.
Snacks: Raw nuts (walnuts rank highest for omega-3 content among nuts), olives, fresh fruit.
The transition does not require perfection on day one. Replace one cooking oil, add two fish meals per week, and swap one refined grain for a whole grain. Build from there.
Weight Loss and Psoriasis (Grade B)
Adipose tissue is not inert. Fat cells secrete TNF-alpha, IL-6, and leptin, all of which amplify the IL-23/IL-17 pathway driving psoriatic inflammation. Obesity doubles the risk of developing psoriasis and worsens existing disease severity.
A systematic review of weight loss interventions in psoriasis patients found that losing 5 to 10% of body weight produced measurable PASI improvement, independent of the method used to achieve the loss. Low-calorie diets, bariatric surgery, and structured Mediterranean interventions all demonstrated skin benefit when weight decreased.
The MEDIPSO trial complicates this picture. Both groups lost weight; only the Mediterranean group cleared. Weight loss likely helps through reduced adipokine secretion, but the anti-inflammatory composition of the diet provides an independent benefit. For overweight psoriasis patients, a Mediterranean approach delivers both mechanisms simultaneously.
Obesity also affects treatment response. Biologic drugs are dosed by weight, and some studies show reduced efficacy in obese patients even at standard doses. Weight loss may improve the response to existing medications, adding another layer of benefit beyond the direct anti-inflammatory effect.
Foods That Trigger Psoriasis Flares
Alcohol (Grade B)
A 2024 meta-analysis calculated the odds ratio for psoriasis at 1.47 among regular drinkers. The dose-response curve showed a 4% increase in odds per gram of daily alcohol intake. For men, the association was stronger: OR 1.84. One standard drink contains approximately 14 grams of alcohol. Three drinks per day increases risk by roughly 56%.
Alcohol disrupts the gut barrier, increasing intestinal permeability and allowing bacterial lipopolysaccharide into systemic circulation. It depletes folate and zinc, both essential for normal keratinocyte turnover. It impairs liver clearance of inflammatory mediators. And it directly stimulates keratinocyte proliferation through acetaldehyde, its primary metabolite.
In the Afifi survey of 1,206 psoriasis patients through the National Psoriasis Foundation, 53.8% of those who reduced alcohol reported skin improvement. That was the highest self-reported response rate of any single dietary change.
Complete elimination produces clearer results than reduction. Even moderate intake maintains the gut permeability disruption that feeds the inflammatory cycle. For patients with psoriatic arthritis (which affects up to 30% of psoriasis patients), the case for alcohol elimination is even stronger. Alcohol's pro-inflammatory effects compound the joint inflammation already driven by the IL-17 pathway.
Ultra-Processed Foods and Refined Sugar (Grade C)
High-glycemic diets increase insulin and insulin-like growth factor 1 (IGF-1), both of which stimulate keratinocyte proliferation and inflammatory cytokine production. Ultra-processed foods carry additional insults: emulsifiers (polysorbate 80, carboxymethylcellulose) damage the intestinal mucus layer in animal models, and advanced glycation end products (AGEs) from deep frying activate toll-like receptors on innate immune cells.
No psoriasis-specific RCT has isolated sugar or processed food as a single variable. The grade stays at C. The mechanistic evidence, combined with the broad health benefits of eliminating these foods, makes this a practical early step with minimal downside.
Red and Processed Meat (Grade B)
Red meat is the primary dietary source of arachidonic acid, the precursor to pro-inflammatory prostaglandins (PGE2) and leukotrienes (LTB4) that amplify psoriatic plaque formation. A 2025 King's College London study found that diets high in red and processed meat correlated with worse psoriasis severity, while plant-rich patterns tracked with lower severity.
Processed meats add nitrates, saturated fat, and AGEs. The combination of arachidonic acid and NF-kB activation creates a compounding inflammatory effect.
Reducing red meat to once per week or less, while increasing fish and legumes, shifts the eicosanoid balance toward anti-inflammatory mediators. This is the same principle behind omega-3 supplementation, applied through food.
The Gluten Question: Only for a Specific Subset
Psoriasis patients carry celiac disease at two to three times the rate of the general population. Approximately 16% of psoriasis patients have elevated anti-gliadin antibodies (AGA), a marker of gluten immune reactivity that falls short of full celiac diagnosis.
The evidence splits sharply by AGA status.
AGA-positive patients (Grade B): Michaelsson et al. (2000, 2003) demonstrated significant PASI reduction in psoriasis patients with elevated AGA who followed a strict gluten-free diet. The improvement reversed when gluten was reintroduced. A 2014 JAAD review confirmed that gluten-free dietary intervention benefits psoriasis patients with serological markers of gluten sensitivity.
AGA-negative patients (Grade C): No controlled trial has shown benefit from gluten elimination in psoriasis patients without AGA elevation. The Afifi survey reported that 53.4% of patients who tried gluten-free diets noticed improvement, but survey data carries heavy recall and placebo bias.
The practical step: request anti-gliadin antibody and anti-tissue transglutaminase (anti-tTG) testing from your dermatologist or primary care physician before committing to long-term gluten elimination. If positive, a strict three-month trial is warranted and likely to produce measurable results. If negative, the significant dietary restriction is harder to justify. For more on how gluten drives joint and systemic inflammation, see our detailed guide.
The Nightshade Debate (Grade C)
Tomatoes, peppers, potatoes, and eggplant contain glycoalkaloids, compounds that may increase intestinal permeability in susceptible individuals. The Afifi survey reported 52.1% improvement among patients who eliminated nightshades. No controlled trial has tested this in psoriasis.
The absence of trial data does not mean the effect is imaginary. Individual variability in glycoalkaloid metabolism is well documented. Some patients respond dramatically to nightshade elimination. Others notice nothing.
A structured elimination trial resolves the question for each patient individually. Remove all nightshades for eight weeks. Photograph plaques at baseline and weekly under consistent lighting. Reintroduce one nightshade at a time over three-day windows, tracking any skin response. If eight weeks of elimination produces no change, nightshades are unlikely to be a personal trigger. If you notice clear worsening on reintroduction, you have useful clinical data specific to your body, regardless of what population-level trials show.
The Gut-Skin Axis: Why Your Intestines Affect Your Plaques
Psoriasis patients harbor a measurably different intestinal microbiome compared to healthy controls. Studies in Frontiers in Microbiology (2025) and Biomedicines (2022) documented reduced populations of Faecalibacterium prausnitzii (a keystone anti-inflammatory species that produces butyrate) and overrepresentation of Prevotella copri (a potentially inflammatory species). This dysbiosis pattern mirrors inflammatory bowel disease, which shares the IL-23/IL-17 pathway with psoriasis and co-occurs in 7 to 11% of psoriasis patients.
The clinical overlap between psoriasis and IBD reinforces this connection. Patients with psoriasis develop IBD at two to three times the rate of the general population. Psoriatic arthritis patients face even higher IBD risk. Both conditions respond to the same biologic drugs because both run on the IL-23/IL-17 circuit.
The mechanism linking gut to skin is direct. When the gut barrier weakens (a process mediated by zonulin signaling, as described by Fasano et al.), bacterial lipopolysaccharide enters systemic circulation. LPS activates dendritic cells, which migrate to skin and produce IL-23. IL-23 drives Th17 cell differentiation. Th17 cells release IL-17, the cytokine directly responsible for keratinocyte hyperproliferation and plaque formation. This is the same pathway targeted by biologic drugs like secukinumab (IL-17 inhibitor) and guselkumab (IL-23 inhibitor).
Butyrate, the short-chain fatty acid produced by F. prausnitzii and other commensal bacteria, plays a protective role at every step. It strengthens tight junction protein expression in intestinal epithelial cells, reducing the permeability that allows LPS translocation. It suppresses NF-kB activation in colonocytes. It promotes regulatory T cell expansion, which counterbalances the Th17 overactivity driving psoriatic inflammation. Psoriasis patients produce less butyrate than healthy controls, and the dietary fiber that feeds butyrate-producing bacteria is precisely what the Mediterranean pattern provides.
Dietary interventions work upstream. A Mediterranean pattern increases microbial diversity, feeds butyrate-producing bacteria, and reduces intestinal permeability. Fermented foods (sauerkraut, kimchi, kefir, plain yogurt) directly introduce beneficial strains. A Stanford study showed that a high-fermented-food diet increased microbial diversity and reduced 19 inflammatory markers over 10 weeks.
For a deeper look at gut barrier repair strategies (the 4R protocol, L-glutamine dosing for intestinal permeability, zinc carnosine), see our gut healing guide.
Omega-3: Food First, Then Supplements (Grade B)
EPA competes directly with arachidonic acid for the COX and LOX enzyme systems. When EPA wins that competition, the resulting eicosanoids (PGE3, LTB5) are anti-inflammatory rather than pro-inflammatory. Resolvins and protectins, produced from EPA and DHA, actively terminate inflammatory cascades rather than merely dampening them.
Multiple RCTs of fish oil supplementation in psoriasis have shown PASI improvement, though effect sizes are modest. The positive trials consistently used doses above 3 g/day of combined EPA and DHA. Lower doses showed minimal benefit, which explains the mixed meta-analysis results: studies using 1 to 2 g/day diluted the pooled effect.
Dietary omega-3 from fatty fish (two to three servings per week) may outperform equivalent supplemental doses because whole fish delivers additional anti-inflammatory compounds: astaxanthin (in salmon), selenium, and vitamin D. Supplementation adds to the dietary base, compounding the shift in eicosanoid balance over weeks and months.
Dosing (supplements): 3 to 4 g combined EPA and DHA per day, split across meals. Triglyceride-form fish oil absorbs better than ethyl ester forms. Look for IFOS or NSF certification for heavy metal testing. Doses above 3 g/day carry mild anticoagulant properties; discuss with your doctor if you take blood thinners. Expect 8 to 12 weeks before measurable PASI changes.
Supplements That Complement Diet
Three supplements carry the strongest evidence as adjuncts to dietary intervention. For a cross-condition overview, see our best supplements for autoimmune disease guide.
Curcumin (Grade B)
Curcumin inhibits NF-kB, the master inflammatory transcription factor activated in psoriatic plaques. An RCT demonstrated a 33% PASI reduction with supplementation. Curcumin also suppresses TNF-alpha, IL-17, and IL-23, the specific cytokines driving psoriasis pathology.
Standard turmeric powder delivers only 3% curcumin by weight, with poor absorption. Clinical trials used bioavailability-enhanced formulations: curcumin with piperine (which increases absorption approximately 2,000%), phytosomal forms, or liposomal delivery. Cooking with turmeric is not therapeutic supplementation.
Dosing: 500 to 1,000 mg/day of bioavailable curcumin with meals. Curcumin has mild anticoagulant properties. Discuss with your doctor if you take blood thinners or methotrexate.
Vitamin D (Grade C for Oral Psoriasis, Grade A for General Autoimmune)
Four RCTs have tested oral vitamin D supplementation for psoriasis. None showed significant PASI improvement. Topical vitamin D analogues (calcipotriol, calcitriol) are effective prescription treatments that work through direct contact with keratinocytes, inhibiting proliferation and promoting differentiation. Oral supplementation does not achieve the same local skin concentrations.
The VITAL trial (2022, BMJ) demonstrated a separate benefit: 2,000 IU/day of vitamin D3 reduced autoimmune disease incidence by 22% over 5.3 years. Correct deficiency for general immune regulation. Do not expect oral vitamin D to clear psoriatic plaques.
Dosing: 2,000 to 4,000 IU/day D3, paired with 100 to 200 mcg vitamin K2 (MK-7 form). Test serum 25(OH)D every 3 months until stable. Target: 40 to 60 ng/mL.
Probiotics (Grade B)
Seven RCTs have shown PASI improvement with various probiotic formulations. The mechanism connects to the gut-skin axis described above: restoring microbial diversity reduces LPS translocation and downstream IL-23 production. Multi-strain formulations with Lactobacillus and Bifidobacterium species at 10 to 50 billion CFU have shown the most consistent results.
Probiotics complement dietary changes rather than replacing them. A Mediterranean pattern feeds beneficial bacteria through prebiotic fiber. Probiotics introduce beneficial strains directly. The combination addresses the psoriasis microbiome from both directions: seeding the gut with anti-inflammatory species while providing the substrate those species need to colonize and produce butyrate.
Dosing: Multi-strain formulation containing Lactobacillus and Bifidobacterium species, 10 to 50 billion CFU daily with food. Expect 8 to 12 weeks before measurable skin changes. Probiotics are generally compatible with all psoriasis medications.
Drug-Diet Interactions
Psoriasis medications carry specific dietary considerations that patients rarely receive clear guidance on.
Methotrexate: Depletes folate by design. Supplement 1 mg folic acid daily or 5 mg weekly, taken 24 to 48 hours after the methotrexate dose (never the same day). Alcohol is absolutely contraindicated with methotrexate due to compounding hepatotoxicity. Even moderate drinking with methotrexate risks liver damage.
Cyclosporine: Grapefruit and Seville oranges inhibit CYP3A4, the enzyme metabolizing cyclosporine. The result is elevated drug levels and increased toxicity risk. Avoid grapefruit juice entirely while on cyclosporine. High-potassium foods (bananas, avocados, potatoes) require monitoring, as cyclosporine can cause hyperkalemia.
Biologics (secukinumab, adalimumab, guselkumab): No specific food contraindications. Vitamin D supplementation is compatible and may support biologic efficacy through shared immune modulation pathways. Curcumin modulates NF-kB (the same pathway biologics target) with no documented adverse interaction. Inform your dermatologist about all supplements when starting biologic therapy.
Acitretin (retinoid): Alcohol consumption converts acitretin to etretinate, a compound with a half-life of 120 days (versus 50 hours for acitretin). This extends the mandatory pregnancy avoidance period from 3 years to indefinite. Alcohol elimination is medically required, not optional, for patients on acitretin.
Fasting and Caloric Restriction (Grade C)
Intermittent fasting and caloric restriction reduce circulating TNF-alpha, IL-6, and CRP in overweight individuals. Ramadan fasting studies in psoriasis patients have shown PASI improvement during the fasting month, though the effect is confounded by simultaneous alcohol elimination and altered eating patterns.
The fasting mimicking diet (FMD), developed by Valter Longo, triggers autophagy and immune cell regeneration over five-day cycles. During the low-calorie phase (roughly 800 calories per day for five days), the body breaks down damaged immune cells through autophagy. During refeeding, stem cell activation regenerates fresh immune cells with a less inflammatory profile. A Nature Medicine RCT (2026) demonstrated benefit in Crohn's disease, with significant reduction in inflammatory markers and clinical improvement. No psoriasis-specific FMD trial exists. The mechanistic rationale is present (immune reset, reduced inflammatory signaling, improved gut barrier function), but the evidence remains preliminary for skin autoimmunity.
Time-restricted eating (limiting food intake to an 8 to 10 hour window) offers a less intensive approach. Preliminary data in metabolic syndrome shows reductions in CRP and inflammatory markers. No psoriasis-specific trial has tested this pattern. The caloric reduction that often accompanies time-restricted eating may contribute to weight loss, which independently improves PASI.
For overweight psoriasis patients, any structured caloric restriction that produces 5 to 10% weight loss will likely improve PASI through adipokine reduction. The Mediterranean approach achieves this without deliberate caloric counting in most patients, because the high fiber and healthy fat content increases satiety. If you pursue fasting protocols alongside a Mediterranean base, maintain the anti-inflammatory food quality during eating windows rather than treating fasting as permission to eat poorly during feeding periods.
Building Your Psoriasis Diet: A Staged Framework
Implementing every change at once overwhelms adherence and makes it impossible to identify which modifications produced benefit. A staged approach solves both problems.
Weeks 1 to 2: Foundation
Transition to a Mediterranean dietary pattern. Replace cooking oils with extra-virgin olive oil. Add fatty fish three times per week. Increase vegetable intake to five or more servings daily. Eliminate alcohol completely. Remove processed foods and refined sugar.
Photograph your plaques on day one under consistent lighting. Same camera distance, same angle. Place a coin in the frame for scale.
Weeks 3 to 4: Supplementation
Add omega-3 (3 g/day EPA plus DHA) and curcumin (500 mg/day bioavailable form with piperine). Begin probiotics if desired (multi-strain, 10 to 50 billion CFU). Correct vitamin D deficiency if testing shows levels below 30 ng/mL.
Month 2: Assessment and Testing
Request anti-gliadin antibody testing. If positive, begin a strict gluten-free trial. Photograph plaques weekly.
Evaluate response to the Mediterranean foundation. If PASI is improving, hold the current approach. If unchanged, consider nightshade elimination as the next variable.
Month 3 to 4: Targeted Elimination
For AGA-positive patients: maintain strict gluten avoidance for at least three months total. For nightshade-suspicious patients: complete the eight-week elimination, then reintroduce one nightshade at a time.
If the autoimmune protocol (AIP) diet interests you, consider it as a step after Mediterranean intervention. AIP eliminates grains, legumes, nightshades, eggs, dairy, nuts, and seeds simultaneously. No psoriasis-specific AIP trial exists (Konijeti 2017 tested AIP in IBD). The restriction burden is high. Start with the approach that has the strongest psoriasis evidence (Mediterranean) before escalating to broader elimination protocols. For a comparison of autoimmune diets across conditions, see our detailed guide.
Frequently Asked Questions
Does the Mediterranean diet work for psoriasis even without weight loss?
Yes. The MEDIPSO trial controlled for this directly. Both the intervention and control groups lost similar amounts of weight. Only the Mediterranean group achieved significant PASI improvement (47.4% reached PASI 75 versus 0% of controls). The benefit derives from the anti-inflammatory composition of the food (oleocanthal in olive oil, omega-3 from fish, polyphenols, prebiotic fiber) rather than from caloric deficit.
How long before dietary changes improve psoriasis?
Eight to sixteen weeks of consistent adherence. The MEDIPSO trial measured outcomes at 16 weeks. Keratinocyte turnover in psoriatic plaques runs on a 3 to 4 day cycle, but shifting the systemic inflammatory environment that drives that turnover takes longer. Alcohol elimination and processed food removal tend to show earlier effects (4 to 6 weeks) because they remove active triggers rather than building anti-inflammatory reserves.
Should I go gluten-free for psoriasis?
Only if you test positive for anti-gliadin antibodies (AGA). Approximately 16% of psoriasis patients carry elevated AGA. In this subset, Michaelsson et al. (2000, 2003) demonstrated significant PASI reduction on a gluten-free diet, with reversal on gluten reintroduction. For AGA-negative patients, no controlled trial supports gluten elimination. Request testing before committing to a dietary restriction that affects every meal.
Are nightshade vegetables bad for psoriasis?
The evidence is anecdotal. The Afifi survey of 1,206 psoriasis patients found 52.1% improvement among those who eliminated nightshades, but no controlled trial exists. Glycoalkaloids in nightshades may increase intestinal permeability in susceptible individuals. An eight-week personal elimination trial is the only way to determine whether nightshades affect your psoriasis specifically.
Can I drink alcohol in moderation with psoriasis?
The dose-response data argues against it. A 2024 meta-analysis showed a 4% increase in psoriasis odds per gram of daily alcohol. One standard drink (14 grams) raises risk measurably. Alcohol increases intestinal permeability, depletes folate and zinc, and directly stimulates keratinocyte proliferation. For patients on methotrexate, alcohol is contraindicated due to hepatotoxicity risk. For patients on acitretin, alcohol converts the drug to a compound with a 120-day half-life, extending pregnancy avoidance indefinitely. Complete elimination produces the clearest benefit.
What supplements help psoriasis alongside diet?
Omega-3 at 3 to 4 g/day EPA plus DHA (Grade B), curcumin at 500 to 1,000 mg/day bioavailable form (Grade B), and probiotics (Grade B based on seven RCTs). Vitamin D corrects deficiency for general autoimmune health but does not clear plaques when taken orally (four negative RCTs). For a broader supplement overview, see our supplements for autoimmune disease guide.
Does psoriasis diet differ from other autoimmune diets?
The Mediterranean framework is consistent across autoimmune conditions, but psoriasis has condition-specific nuances. The MEDIPSO trial provides Grade A evidence for Mediterranean diet in psoriasis specifically, which most other autoimmune conditions lack. The gluten-free subset (AGA-positive patients) is unique to psoriasis and celiac comorbidity. Alcohol elimination carries stronger evidence in psoriasis than in most other autoimmune conditions due to the direct keratinocyte proliferation mechanism. For a comparison of autoimmune diets across conditions, see our guide. For a broader look at psoriasis natural treatment including stress management and supplementation protocols, see our comprehensive guide.
Build Your Personalized Protocol
Diet forms one layer of an evidence-based psoriasis strategy. Your optimal approach depends on disease severity, current medications, gut health status, AGA antibody status, and body composition. Take the free 3-minute AutoimmuneFinder quiz to build a personalized, evidence-graded protocol matched to your specific profile.
This article is for educational purposes only and does not constitute medical advice. Psoriasis is a chronic inflammatory condition that may require ongoing dermatological supervision. Do not start, stop, or change any diet, supplement, or medication without consulting your dermatologist or primary care physician. All dosage recommendations should be discussed with your healthcare provider before implementation.